The main component, matrine, can inhibit MMP-9 and MMP-2 activation in highly metastatic human breast cancer MDA-MB-231 cells, reduce the mRNA expression levels of MMP-9 and MMP-2, and finally inhibiting tumor cell invasion (Wang, 2018). Here, MMP9 is linked to neoplasm.